Status:
COMPLETED
A Home-based Lifestyle Intervention for Optimizing Surgical Outcomes Among Urinary Bladder Cancer Patients
Lead Sponsor:
University of Utah
Conditions:
Bladder Cancer
Cystectomy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test a randomized, controlled diet and physical activity intervention designed to be simple and address barriers to participation in lifestyle intervention among 16 uri...
Detailed Description
Urinary bladder cancer is the fourth leading cancer in men in the US, leading to 18,000 deaths among men and women annually.1 The survival rate is 69% for localized disease, 36% for regional disease, ...
Eligibility Criteria
Inclusion
- Adult patients 18 years or older.
- Newly diagnosed urinary bladder cancer patients indicated for cystectomy with or without neo-adjuvant therapy; Treated with surgery at the Huntsman Cancer Institute
- Have reliable, consistence access to the internet for study procedures
- Inclusion of Individuals across the Lifespan: The proposed trial will enroll 20 adults who have been diagnosed with bladder cancer. The age range of participants to be recruited is 18 years or older. Bladder cancer is generally a disease of older age and is exceedingly rare in children. According to the American Cancer Society, average age at diagnosis is 73.1 Therefore, we are unable to include children in this trial.
- Inclusion of Women, Minorities, and Children: It is anticipated that 20% will be female; 80% male. Racial distribution is projected to be as follows: 97% white, 1% Native Hawaiian or Pacific Islander; 1% American Indian/ Alaska Native; 1% Asian; \<1% Black. Approximately 96% will be Non-Hispanic.
Exclusion
- Special dietary requirements (i.e., allergies and intolerances, or other clinically prescribed diet).
- Unable to provide informed consent or read, write, or fill in questionnaires in English
Key Trial Info
Start Date :
June 4 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 8 2025
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT06002269
Start Date
June 4 2024
End Date
July 8 2025
Last Update
July 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huntsman Cancer Institute
Salt Lake City, Utah, United States, 84112